Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Exploring the Frontier of Multiomics: DeciBio Q&A with Peter Fromen, CEO of biomodal
A Q&A with Peter Fromen, CEO of biomodal, emphasizing the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
November 28, 2023
DeciBio Q&A
Exploring the Frontier of Multiomics: DeciBio Q&A with Peter Fromen, CEO of biomodal
A Q&A with Peter Fromen, CEO of biomodal, emphasizing the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
November 28, 2023
Liquid Biopsy
Genomics Market
multiomics
Blog Article
Clinical Diagnostics
Illuminating the Future of Medicine: Insights from SITC 2023 and AMP 2023
AMP and SITC 2023 both showcased the latest advancements and highlighted the shifting paradigms in patient care and laboratory practices.
November 27, 2023
Blog Article
Clinical Diagnostics
Illuminating the Future of Medicine: Insights from SITC 2023 and AMP 2023
AMP and SITC 2023 both showcased the latest advancements and highlighted the shifting paradigms in patient care and laboratory practices.
November 27, 2023
AI / Machine Learning
Immuno-Oncology
Spatial Biology
Webinar
Pharma & Biotech
Revolutionizing Medicine- Navigating the Future of Cell Therapy Manufacturing (DeciBio Webinar)
DeciBio Consulting shares their perspective on how the tools supporting cell therapy manufacturing have evolved and where there is room for continued growth.
November 21, 2023
Webinar
Pharma & Biotech
Revolutionizing Medicine- Navigating the Future of Cell Therapy Manufacturing (DeciBio Webinar)
DeciBio Consulting shares their perspective on how the tools supporting cell therapy manufacturing have evolved and where there is room for continued growth.
November 21, 2023
Cell & Gene Tx
.png)
Newsletter Update
Digital Health and Informatics | Q3 2023 Update
The third quarter has come to a close, with numerous developments including partnerships across digital therapeutics and informatics, and regulatory approvals in AI / imaging.
November 20, 2023
Newsletter Update
Digital Health and Informatics | Q3 2023 Update
The third quarter has come to a close, with numerous developments including partnerships across digital therapeutics and informatics, and regulatory approvals in AI / imaging.
November 20, 2023
Digital Health
Health Technology Market
Women's Health
Medical Devices
Blog Article
Clinical Diagnostics
The cancer early detection (EDx) race continues: Industry KOL offers perspective on current excitement and challenges in the early cancer detection space
Our team is excitedly tracking the evolving cancer early detection space. Discover highlights from last year’s activity.
November 20, 2023
Blog Article
Clinical Diagnostics
The cancer early detection (EDx) race continues: Industry KOL offers perspective on current excitement and challenges in the early cancer detection space
Our team is excitedly tracking the evolving cancer early detection space. Discover highlights from last year’s activity.
November 20, 2023
Precision Medicine
EDx
Liquid Biopsy
Biomarkers
Diagnostics Market
In The Press
Pharma & Biotech
ADCs as biological missiles for targeted therapies
ADC clinical pipeline as per therapeutic area: Infographic developed by Joe Daccache using DeciBio’s TheraTrack platform
November 20, 2023
In The Press
Pharma & Biotech
ADCs as biological missiles for targeted therapies
ADC clinical pipeline as per therapeutic area: Infographic developed by Joe Daccache using DeciBio’s TheraTrack platform
November 20, 2023
adjuvant cell therapy
Cell & Gene Tx
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved